Ludwig's angina is a life-threatening cellulitis that involves the submandibular and sublingual spaces. It often occurs after an infection of the roots of the teeth. However, modern dental care and use of antibiotics for oral infections have made Ludwig's angina rare. We present here a cancer patient exhibiting the sequential features of bisphosphonate related osteonecrosis of the jaw on bone scan complicating with Ludwig's angina. This report highlights the need for medical practitioners to be alert to these rare combinations in the compromised patient after bisphosphonate therapy. To the best of our knowledge, no case of Ludwig's angina secondary to osteonecrosis of the jaw has been reported.
Introduction
Ludwig's angina is an infection of the submandibular and sublingual spaces. It can potentially lead to a fatal airway obstruction. It often occurs after an infection of the mandible. We present here a cancer patient exhibiting the sequential features of bisphosphonate-related osteonecrosis of the jaw (BRONJ) on bone scan and complicating with Ludwig's angina. This report highlights that practitioners should be alert to these rare combinations in the compromised patient after bisphosphonate therapy.
Case Report
An 83-year-old man, who had been diagnosed 2 years earlier with prostate cancer, presented with submandibular swelling and inability to swallow saliva for 1 week. With preliminary assessment as Ludwig's angina at a local hospital, and patient had undergone antibiotic prophylaxis and to abscess drainage prior to the referral. He was nonfebrile and not in respiratory distress. Computed tomography of his neck showed a significant inflammation with abscess and fistula formation in the left submandibular space. Presence of periosteal reaction, osteolytic and osteoblastic change, bone sequestration, and destruction of the mandible were noted (Fig. 1) .
Tc-99m methylene diphosphonate bone scan (Fig. 2 ) exhibited intense bone lesion in the lower jaw (black arrow) and evidence of distant bone metastasis (open arrows). He was admitted to the dental ward for airway observation and further treatment in September 2010. The aerobic and anaerobic cultures of his blood yielded negative results. Empirical use of 1200 mg augmentin and 500 mg metronidazole intravenously q. 8 hours was given. Subsequently the patient received sequestectomy of the mandible and oral mucosa flap reconstruction. During the operation, an open wound over the left Conflicts of interest: The authors declare that there are no conflicts of interest related to the subject matter or materials discussed in this article.chin, deep caries, and sequestrum formation in left mandible were found. Histologically, inflammatory cell infiltration, and granulation of soft-tissue were observed. Bone sequestration, necrosis, and ingrowth of squamous epithelium in the mandible were also noted (Fig. 3) . A diagnosis of Stage 2 BRONJ, distinguished by bone exposure with soft-tissue and mandible infection, was confirmed. His pus culture yielded no bacterial growth due to the recent antibiotics exposure. The patient was then switched to 1 g augmentin tablet twice daily. Subsequent follow-up at 2 weeks and 3 months at the outpatient clinic showed a progressive resolution of soft-tissue swelling. Thereafter, our service had no further contact with the patient.
Regarding his past medical history (Fig. 4) , the patient had prostate cancer (Gleason score 4 þ 3) with urinary bladder invasion and distant skeletal spreading that was treated with palliative prostatectomy in October 2008, and intravenous zoledronic acid monthly thereafter. With partial response of metastatic disease after 1 year of the therapy, the patient sought dental care for a nonhealing tooth socket in the left lower jaw. He underwent several courses of antibiotics therapy with no significant improvement. In June 2010, an area of infected and exposed necrotic bone in the left mandible was noted, consistent with Stage 2 BRONJ according to the American Association of Oral and Maxillofacial Surgeons criteria. Zoledronic acid was then discontinued and hormone therapy was provided.
Discussion
Bisphosphonates are inhibitors of osteoclastic bone resorption, indicated for the treatment of an array of bone disorders. Suppressed bone turnover by bisphosphonates adds to microdamage accumulation and danger of infections. BRONJ, which was first described in 2003, 1 is a rare but serious side effect of treatment with bisphosphonates. About 95% of cases occurred among cancer patients receiving highdose intravenous bisphosphonates. 2 The working definitions of BRONJ have been proposed as the development of necrotic bone in the oral cavity of a patient who is receiving bisphosphonate treatment, despite adequate treatment for 8 weeks, without malignancy and no prior radiotherapy to the head and neck. 3 Patients with BRONJ are categorized into three stages according to the clinical signs and symptoms. Briefly, patients with Stage 1 disease have exposed bone but are asymptomatic. Stage 2 disease is characterized by exposed bone with regional soft-tissue infection. Patients exhibiting exposed bone associated with soft-tissue infection, and accompanied by pathologic fracture, oralcutaneous fistula, or osteolysis extending to the inferior border are considered Stage 3. The underlying etiology and the predilection of BRONJ remain unclear. Estilo et al 4 reported that Actinomyces colonization was found in all 310 biopsy cases. Other authors have described that biofilms could be . After 1 year of therapy with partial response of metastatic disease, the patient sought dental treatment for a nonhealing tooth socket in the left mandible (black arrow). In June 2010, a necrotic bone in the left mandible was noted clinically, consistent with the criteria of bisphosphonate-related osteonecrosis of the jaw (black arrow). Hormone therapy was given instead of zoledronic acid. Ludwig's angina developed in September 2010 (Fig. 2) .
identified on the bone/tooth and mucosal surfaces around BRONJ that are composed of Actinomyces and other organisms. 4, 5 However, it is unclear if bisphosphonates causes direct toxicity to the bone and/or soft tissues, which is infected secondarily, 6, 7 or if infection is the immediate cause exacerbated by the use of bisphosphonates. Nevertheless, necrotic bone may be the infectious source in the oral cavity, especially in immunocompromised patients who are under chemotherapy. Furthermore, the lesion may progress to cause a serious complication, as was the case in our patient.
BRONJ appears to be time-dependent with higher risk after long-term use of bisphosphonate. 8 Our patient had been treated with zoledronic acid for >1 year. Although he was followed-up by appropriate dental care, the presence of osteonecrosis was not noticeable initially. However, a small focus had been seen in the lower jaw about 19 months before the patient's surgeon was aware of his problems and took intervention (Fig. 4) . It is not clear whether the radiotracer deposits in BRONJ bone or the surrounding reactive bone. 4 Nevertheless, increased uptake on bone scintigraphy is noted in a majority of BRONJ cases, varying from 60% to >90%.
4,9
Dore et al 10 described the high sensitivity of bone scanning in identifying BRONJ in the early stage, especially with singlephoton emission computed tomography/computed tomography. Generally speaking, bone scintigraphy appears to be a sensitive but not specific modality in this setting and is considered valuable in delineating early BRONJ in most cases.
Ludwig's angina, characterized as a rapidly progressive gangrenous cellulitis of the mouth floor, is an ear, nose, and throat emergency. It can lead to lethal consequences due to airway obstruction. Most cases of Ludwig's angina are odontogenic in etiology, primarily resulting from infections of the second and third molars, where BRONJ happens to occur most readily. Once infection develops, it spreads contiguously to the sublingual space and may spread to the deep neck space.
Although no similar case has been reported, the authors suggest that BRONJ may be a risk factor of submandibular and sublingual infection, and when a cancer patient is treated with zoledronic acid, Tc-99m methylene diphosphonate bone scintigraphy is considered as a reasonably effective diagnostic tool to identify BRONJ in the early stage.
